TTrialPathMatch Me to Trials
← Back to trials
RecruitingPostpartum Depression (PPD)Self-EfficacyParental Anxiety

NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)

Eligible age

18+ yrs

Accepts

Women

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The study's objective is to conduct a Phase II randomized controlled trial examining the preliminary efficacy of the VoiceLove app compared to usual care on maternal postpartum depression in mothers with infants admitted to the Neonatal Intensive Care Unit (NICU). Primary aim: Assess the effects of VoiceLove on maternal postpartum depression, measured by the Edinburgh Postnatal Depression Scale (EPDS). The estimates from this study will be used for a future definitive Phase III trial. Secondary aim: Assess feasibility, acceptability, and patterns of communication and engagement among mothers, partners, and NICU clinicians during the NICU hospitalization, measured through app usage metrics, satisfaction surveys, and qualitative interviews. Additionally, we will evaluate effects of infant length of stay.

Sponsor: Vanderbilt University Medical Center

You may qualify if…

  • 1. Infant:
  • 1. Admitted to the neonatal intensive care unit (NICU)
  • 2. Not readmitted after discharge from the NICU
  • 3. Expected to survive at least 2 weeks
  • 4. Expected to be admitted to the NICU for at least 2 weeks
  • 5. Singleton gestation
  • 2. Mother:
  • 1. Age ≥ 18 years old

You may not qualify if…

  • 1. Infant
  • a. Re-admission to NICU
  • 2. Mother
  • 1. No access to an Android or iOS smartphone
  • 2. Unwilling to download the VoiceLove NICU app to their personal smartphone and unwilling to accept the terms and conditions of the VoiceLove app
  • 3. No personal email address
  • 4. Incarcerated at time of delivery or postpartum
  • 5. Inability to obtain informed consent

Where it's recruiting

Tennessee

Nashville

Source: ClinicalTrials.gov · NCT07214597 · last updated 2026-06-17